TITLE

Surgical ablation of post-infarction ventricular tachycardia guided by mapping in sinus rhythm: long term results

AUTHOR(S)
Pirk, Jan; Bytesnik, Jan; Kautzner, Josef; Peichl, Petr; Vancura, Vlastimil; Lefflerova, Katerina; Skalsky, Ivo; Vinduska, Vladimir
PUB. DATE
August 2004
SOURCE
European Journal of Cardio-Thoracic Surgery;Aug2004, Vol. 26 Issue 2, p323
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: Some patients after myocardial infarction have an increased risk of malignant ventricular tachyarrhythmias (VTA) or sudden cardiac death. The aim of the study was to evaluate long-term results of surgical ablation of an arrhythmogenic substrate guided by simplified intraoperative mapping of pathological ventricular electrograms during sinus rhythm. Methods: The study population consisted of 77 patients (9 women; mean age 62.4±8.5 years) with previous Q-wave myocardial infarction and at least one documented episode of sustained VT/VF more than one month after the last infarction. The left ventricular ejection fraction was 31.3±8.8%. All but eight patients had clinical indication for concomitant coronary artery bypass surgery. All underwent preoperative electrophysiologic study. Intraoperative epicardial and endocardial mapping during sinus rhythm was performed using a multielectrode with 16 bipolar electrodes in combination with a multichannel recording system. Myocardial regions revealing fractionated, low amplitude signals lasting ≥130 ms were surgically excised or cryoablated. All surviving patients were restudied within one to two weeks after surgery using identical programmed electrical stimulation protocol. Results: Five (6.5%) patients died in the perioperative (30-days) period. In the remaining cohort, inducibility of any sustained VTA after surgical procedure was observed in 21 subjects (29.2%). An implantable cardioverter-defibrillator (ICD) was implanted in these patients. Recurrence of sustained VTA was documented during follow-up period in two patients who were noninducible after the surgery (at the month 10 and 22, respectively), and both received ICD as well. No patient died of sudden cardiac death. In 14 ICD patients, no significant VTA was documented during the mean follow-up of 37.3±23.2 months. Altogether, 61 from the 72 patients surviving the surgery (84.7%) remained free of spontaneous recurrences of VTA during the follow-up. Conclusions: Surgical ablation of an arrhythmogenic substrate guided by simplified intraoperative mapping in normothermic heart during sinus rhythm appears to be both safe and efficacious procedure that prevents recurrences of VTA in a substantial proportion of patients.
ACCESSION #
14036744

 

Related Articles

  • Torsades de pointes. Dulak, Sally Beattie; Metules, Terri J. // RN;Oct2004, Vol. 67 Issue 10, p24ac1 

    Focuses on torsades de pointes, a lethal form of ventricular tachycardia. Polymorphic QRS complexes that appear to twist around the isoelectric line; Key to preventing sudden cardiac death.

  • Implantable devices for treating tachyarrhythmias. Houghton, Timothy; Kaye, Gerry C.; Grech, Ever D. // BMJ: British Medical Journal (International Edition);8/9/2003, Vol. 327 Issue 7410, p333 

    Pacing treatment for tachycardia control has achieved success, notably in supraventricular tachycardia. Pacing termination for ventricular tachycardia has been more challenging, but an understanding of arrhythmia mechanisms, combined with increasingly sophisticated pacemakers and the ability to...

  • Therapeutic Medical Hypothermia-A Multispecialty Approach. Nanda, Sudip; Patel, Nainesh C.; Bhatt, Surya P.; Mathiesen, Claranne; Castaldo, John; Sharma, Shree G.; Longo, Santo // Recent Patents on Cardiovascular Drug Discovery;Nov2010, Vol. 5 Issue 3, p212 

    Cardiac arrest remains one of the most common causes of death in developed countries. Those who survive may have significant neurologic morbidity. In the current decade, therapeutic medical hypothermia (TMH) has emerged as the only treatment that unequivocally improves neurologic outcomes in...

  • The long QT syndrome: Therapeutic implications of a genetic diagnosis. Shimizu, Wataru // Cardiovascular Research;Aug2005, Vol. 67 Issue 3, p347 

    Abstract: The congenital long QT syndrome (LQTS) is a hereditary disorder characterized by a prolonged QT interval and a polymorphic ventricular tachycardia, known as Torsade de Pointes (TdP), leading to severe cardiac events such as syncope and/or sudden cardiac death. Molecular genetic studies...

  • Adaptive Match Filter Based Method for Time vs. Amplitude Characterization of Microvolt ECG T-Wave Alternans. Laura Burattini; Roberto Burattini // Annals of Biomedical Engineering;Sep2008, Vol. 36 Issue 9, p1558 

    Abstract  To develop a new method for non-invasive identification of patients prone to ventricular tachyarrhythmia and sudden cardiac death, an adaptive match-filter (AMF) was applied to detect and characterize T-wave alternans (TWA) in 200 coronary artery diseased (CAD) patients compared...

  • Molecular Predictors of Drug-induced Prolongation of the QT Interval. Dilaveris, Polychronis E.; Stefanadis, Christodoulos I. // Current Medicinal Chemistry - Cardiovascular & Hematological Age;Apr2005, Vol. 3 Issue 2, p105 

    One of the most common causes of drug withdrawal from the market is the prolongation of the QT interval associated with polymorphic ventricular tachycardia or torsade de pointes (TdP) that can degenerate into ventricular fibrillation and sudden cardiac death. Cardiac and non-cardiac drugs...

  • Fighting cardiac arrest: Automated external defibrillator. Kumar, V.; Adhikari, K. M.; Singh, Y. D. // Indian Journal of Critical Care Medicine;Oct-Dec2003, Vol. 7 Issue 4, p242 

    Ventricular tachyarrhythmias�Ventricular fibrillation (VF) and Ventricular tachycardia (VT) account for most of out-of-hospital sudden cardiac arrest. Defibrillation is the specific therapy for VF/pulseless VT. Time to defibrillation is the most important determinant of survival from these...

  • Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. Kass, Robert S.; Moss, Arthur J. // Journal of Clinical Investigation;Sep2003, Vol. 112 Issue 6, p810 

    The congenital long QT syndrome is a rare disorder in which mutation carriers are at risk for polymorphic ventricular tachycardia and/or sudden cardiac death. Discovery and analysis of gene mutations associated with variants of this disorder have provided novel insight into mechanisms of cardiac...

  • Gene therapy for ventricular tachyarrhythmias. Donahue, J K // Gene Therapy;Jun2012, Vol. 19 Issue 6, p600 

    Cardiac arrest is the leading cause of death in the United States and other developed countries. Ventricular tachyarrhythmias are the most prominent cause of cardiac arrest, and patients with structural heart disease are at increased risk for these abnormal heart rhythms. Drug and device...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics